Nachrichten zur Hims & Hers Health Aktie

In a report released today, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers…

Hims & Hers Health (NYSE: HIMS), a telehealth platform, has taken a beating recently, with shares plummeting 60% from February…

$60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure…

SAN FRANCISCO--(BUSINESS WIRE)--Apr 14, 2025--…

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it…

New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Jefferies & Co: Glen Santangelo, Analyst von Jefferies & Co, bestätigt die…

O Shaughnessy Asset Management LLC bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free…

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price target dropped by stock analysts at Truist Financial…

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…

Jefferies raises Hims & Hers stock target to $25, maintains hold…

Jefferies raises Hims & Hers stock target to $25, maintains hold…

Jefferies analyst Glen Santangelo raised the firm’s price target on Hims Hers to $25 from $21 and keeps a…

The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and…

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57%…

Hims & Hers health COO Melissa Baird sells $910,687 in stock…

Hims & Hers health COO Melissa Baird sells $910,687 in stock…

Hims & Hers health COO Melissa Baird sells $910,687 in stock…

[content-module:CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made an…